Sattar, Naveed

Elimination of Electrically Induced Iontophoretic Artefacts: Implications for Non-Invasive Assessment of Peripheral Microvascular Function

Ferrell, W. R., Ramsay, J. E., Brooks, N., Lockhart, J. C., Dickson, S., McNeece, G. M., Greer, I. A., & Sattar, N. (2002) · Journal of Vascular Research

Advancements in Transdermal Drug DeliveryThermoregulation and physiological responses

Cited by 76

Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity

Sattar, N., Presslie, C., Rutter, M. K., & McGuire, D. K. (2024) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 70

Potential Effects of Bariatric Surgery on the Incidence of Heart Failure and Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus and Obesity and on Mortality in Patients With Preexisting Heart Failure: A Nationwide, Matched, Observational Cohort Study

Höskuldsdóttir, G., Sattar, N., Miftaraj, M., Näslund, I., Ottosson, J., Franzén, S., Svensson, A., & Eliasson, B. (2021) · Journal of the American Heart Association

Bariatric Surgery and OutcomesHeart Failure Treatment and Management

Cited by 70

Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes

Yates, T., Davies, M. J., Gray, L. J., Webb, D., Henson, J., Gill, J. M. R., Sattar, N., & Khunti, K. (2010) · Preventive Medicine

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

Time course of normalization of functional β-cell capacity in the diabetes remission clinical trial after weight loss in type 2 diabetes

Zhyzhneuskaya, S. V., Al-Mrabeh, A., Peters, C., Barnes, A., Aribisala, B., Hollingsworth, K. G., McConnachie, A., Sattar, N., Lean, M. E. J., & Taylor, R. (2020) · Diabetes Care

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 70

Treating chronic diseases without tackling excess adiposity promotes multimorbidity

Sattar, N., McMurray, J. J. V., McInnes, I. B., Aroda, V. R., & Lean, M. E. J. (2023) · The Lancet Diabetes & Endocrinology

Chronic Disease Management StrategiesObesity, Physical Activity, Diet

Cited by 69

In vivo multiplex molecular imaging of vascular inflammation using surface-enhanced Raman spectroscopy

Noonan, J., Asiala, S. M., Grassia, G., MacRitchie, N., Gracie, K., Carson, J., Moores, M., Girolami, M., Bradshaw, A. C., Guzik, T. J., et al. (2018) · Theranostics

Gold and Silver Nanoparticles Synthesis and ApplicationsSpectroscopy Techniques in Biomedical and Chemical Research

Cited by 69

Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes

Feinkohl, I., Keller, M., Robertson, C. M., Morling, J. R., Williamson, R. M., Nee, L. D., McLachlan, S., Sattar, N., Welsh, P., Reynolds, R. M., et al. (2013) · Diabetes Care

Dementia and Cognitive Impairment ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 69

Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021

Malik, M. E., Falkentoft, A. C., Jensen, J., Zahir, D., Parveen, S., Alhakak, A., Andersson, C., Petrie, M. C., Sattar, N., McMurray, J. J. V., et al. (2023) · The Lancet Regional Health - Europe

Diabetes Treatment and ManagementMedication Adherence and Compliance

Cited by 67

PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population

Postmus, I., Trompet, S., de Craen, A. J. M., Buckley, B. M., Ford, I., Stott, D. J., Sattar, N., Slagboom, P. E., Westendorp, R. G. J., & Jukema, J. W. (2013) · Journal of Lipid Research

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 67

Type 2 diabetes partitioned polygenic scores associate with disease outcomes in 454,193 individuals across 13 cohorts

DiCorpo, D., LeClair, J., Cole, J. B., Sarnowski, C., Ahmadizar, F., Bielak, L. F., Blokstra, A., Bottinger, E. P., Chaker, L., Chen, Y.-D. I., et al. (2022) · Diabetes Care

Genetic Associations and EpidemiologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 66

Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials

Lee, M. M. Y., Sattar, N., Pop-Busui, R., Deanfield, J., Emerson, S. S., Inzucchi, S. E., Mann, J. F. E., Marx, N., Mulvagh, S. L., Poulter, N. R., et al. (2025) · Diabetes Care

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 63

Tumour necrosis factor α blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study

Peters, M. J. L., Welsh, P., McInnes, I. B., Wolbink, G., Dijkmans, B. A. C., Sattar, N., & Nurmohamed, M. T. (2010) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesHeart Failure Treatment and Management

Cited by 62

Dose-response association between device-measured physical activity and incident dementia: a prospective study from UK Biobank

Petermann-Rocha, F., Lyall, D. M., Gray, S. R., Gill, J. M. R., Sattar, N., Welsh, P., Quinn, T. J., Stewart, W., Pell, J. P., Ho, F. K., et al. (2021) · BMC Medicine

Dementia and Cognitive Impairment ResearchPhysical Activity and Health

Cited by 60

Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby)

Sattar, N., Welsh, P., Leslie, W. S., Thom, G., McCombie, L., Brosnahan, N., Richardson, J., Gill, J. M. R., Crawford, L., & Lean, M. E. J. (2023) · The Lancet Regional Health - Southeast Asia

Dietary Effects on HealthDiabetes Treatment and Management

Cited by 58

Network meta-analysis of randomized trials evaluating the comparative efficacy of lipid-lowering therapies added to maximally tolerated statins for the reduction of low-density lipoprotein cholesterol

Toth, P. P., Bray, S., Villa, G., Palagashvili, T., Sattar, N., Stroes, E. S. G., & Worth, G. M. (2022) · Journal of the American Heart Association

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 56

Prevalent and incident heart failure in cardiovascular outcome trials of patients with type 2 diabetes.

Greene, S. J., Vaduganathan, M., Khan, M. S., Bakris, G. L., Weir, M. R., Seltzer, J. H., Sattar, N., McGuire, D. K., Januzzi, J. L., Stockbridge, N., et al. (2018) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 56

Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People?

Stott, D. J., Falconer, A., Kerr, G. D., Murray, H. M., Trompet, S., Westendorp, R. G. J., Buckley, B., De Craen, A. J. M., Sattar, N., & Ford, I. (2008) · Journal of the American Geriatrics Society

Dementia and Cognitive Impairment ResearchAlcohol Consumption and Health Effects

Cited by 55

Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort

Taylor, R., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Sattar, N., Welsh, P., Peters, C., Zhyzhneuskaya, S., et al. (2018) · Diabetologia

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 55

Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink

Sattar, N., & McGuire, D. K. (2018) · Circulation

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 53

Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical Trials

Apperloo, E. M., Tuttle, K. R., Pavo, I., Haupt, A., Taylor, R., Wiese, R. J., Hemmingway, A., Cherney, D. Z. I., Sattar, N., & Heerspink, H. J. L. (2025) · Diabetes Care

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 53

Effects of tirzepatide versus insulin glargine on cystatin C-based kidney function: a SURPASS-4 post hoc analysis

Heerspink, H. J. L., Sattar, N., Pavo, I., Haupt, A., Duffin, K. L., Yang, Z., Wiese, R. J., Wilson, J. M., Hemmingway, A., Cherney, D. Z. I., et al. (2023) · Diabetes Care

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 53

Development and validation of a cardiovascular risk prediction model in type 1 diabetes

McGurnaghan, S. J., McKeigue, P. M., Read, S. H., Franzen, S., Svensson, A.-M., Colombo, M., Livingstone, S., Farran, B., Caparrotta, T. M., Blackbourn, L. A. K., et al. (2021) · Diabetologia

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 53

Predictors of ≥15% weight reduction and associated changes in cardiometabolic risk factors with tirzepatide in adults with type 2 diabetes in SURPASS 1-4

Małecki, M. T., Batterham, R. L., Sattar, N., Levine, J. A., Rodríguez, Á., Bergman, B. K., Wang, H., Ghimpeteanu, G., & Lee, C. J. (2023) · Diabetes Care

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 52